for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
World News

Russia to begin Phase III trials of second COVID-19 vaccine in Nov-Dec - TASS

MOSCOW (Reuters) - Russia will begin Phase III trials of a second potential vaccine against COVID-19, developed by Siberia’s Vector Institute, in November-December, the TASS news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Friday.

Early-stage clinical trials for the vaccine were completed on Wednesday.

Writing by Alexander Marrow; Editing by Polina Ivanova

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up